Jules Bordet Institute
Clinical trials sponsored by Jules Bordet Institute, explained in plain language.
-
Five-Session radiation blitz tested for returning prostate cancer
Disease control Recruiting nowThis study is testing if a much shorter, more intense radiation schedule can control prostate cancer that returns after surgery as well as the standard, longer treatment. It will compare a 5-session treatment to the usual 20-35 sessions. The main goal is to see if the shorter tre…
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Finding the best cancer treatment strategy for seniors
Disease control Recruiting nowThis study compares two standard treatment approaches for older adults (age 70+) with locally advanced rectal cancer. Researchers want to determine whether giving all chemotherapy before surgery works better and is safer than the traditional approach of giving some chemotherapy a…
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New scan could match patients to best drug after treatment fails
Disease control Recruiting nowThis study is for people with advanced HER2-positive breast cancer whose disease has worsened on a specific drug (T-DXd). It tests if a special imaging scan (HER2-PET/CT) can predict who might benefit from switching to another targeted drug (T-DM1). Patients get the scan and a bi…
Phase: PHASE2 • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Targeted radiation zaps tumors, could keep breast cancer drugs working longer
Disease control Recruiting nowThis study is for women with a specific type of advanced breast cancer (ER+/HER2-) whose current hormone-based medications are starting to fail at 1-3 spots in the body. Researchers want to see if using very precise, high-dose radiation (called SBRT) on just those few growing tum…
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Hormone shots aim to ease final days for dying men
Symptom relief Recruiting nowThis study tests whether regular testosterone injections can improve quality of life for men with low testosterone who are receiving end-of-life care. Researchers will give injections every two weeks to 20 men and track changes in their daily function, symptoms, and comfort. The …
Phase: EARLY_PHASE1 • Sponsor: Jules Bordet Institute • Aim: Symptom relief
Last updated Apr 01, 2026 14:43 UTC
-
Can a simple test predict who will benefit from prostate cancer radiation?
Knowledge-focused Recruiting nowThis study aims to understand why some prostate cancer patients don't respond to a targeted radiation treatment called 177Lu-PSMA-RLT. Researchers will measure how much radiation reaches tumors after one treatment cycle to see if this measurement can predict which patients will u…
Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC
-
Scientists launch major brain metastasis study to crack Cancer's toughest puzzle
Knowledge-focused Recruiting nowThis research program aims to better understand how and why cancer spreads to the brain and spinal cord (CNS metastases) in patients with solid tumors like breast cancer, lung cancer, and melanoma. It will enroll 600 patients at high risk for this complication to collect detailed…
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC
-
Looking back to prevent future pain: major study investigates common complication after complex cancer surgery
Knowledge-focused Recruiting nowThis study looks back at the medical records of 500 patients who had major surgery for advanced abdominal cancers. The goal is to understand how often a painful complication called an incisional hernia happens after this surgery, what factors make it more likely, and how surgeons…
Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC